CIGNA Co. (CI) EVP John M. Murabito Sells 28,037 Shares

CIGNA Co. (NYSE:CI) EVP John M. Murabito sold 28,037 shares of CIGNA stock in a transaction on Wednesday, January 10th. The shares were sold at an average price of $205.68, for a total transaction of $5,766,650.16. Following the completion of the transaction, the executive vice president now directly owns 60,290 shares of the company’s stock, valued at approximately $12,400,447.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Shares of CIGNA Co. (NYSE CI) opened at $213.39 on Monday. CIGNA Co. has a 52-week low of $133.52 and a 52-week high of $213.73. The stock has a market cap of $52,611.30, a PE ratio of 23.37, a PEG ratio of 1.45 and a beta of 0.51. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.39 and a quick ratio of 0.39.

CIGNA (NYSE:CI) last announced its earnings results on Thursday, November 2nd. The health services provider reported $2.83 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.36 by $0.47. CIGNA had a net margin of 5.74% and a return on equity of 18.85%. The business had revenue of $10.38 billion for the quarter, compared to analyst estimates of $10.17 billion. During the same quarter last year, the business earned $1.94 earnings per share. The company’s revenue for the quarter was up 5.1% compared to the same quarter last year. sell-side analysts forecast that CIGNA Co. will post 10.34 EPS for the current year.

A number of research analysts have weighed in on the stock. ValuEngine raised shares of CIGNA from a “hold” rating to a “buy” rating in a report on Sunday, December 31st. Goldman Sachs Group assumed coverage on shares of CIGNA in a report on Wednesday, January 3rd. They issued a “neutral” rating and a $247.00 price objective for the company. BMO Capital Markets initiated coverage on shares of CIGNA in a report on Monday, October 16th. They issued a “market perform” rating and a $210.00 price objective for the company. Morgan Stanley lifted their target price on shares of CIGNA from $195.00 to $223.00 and gave the company an “overweight” rating in a research report on Friday, November 3rd. Finally, Citigroup lifted their target price on shares of CIGNA from $198.00 to $231.00 and gave the company a “buy” rating in a research report on Friday, November 3rd. Three equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the stock. CIGNA has a consensus rating of “Buy” and a consensus target price of $205.18.

A number of institutional investors and hedge funds have recently bought and sold shares of CI. Investec Asset Management LTD boosted its position in CIGNA by 35.4% during the third quarter. Investec Asset Management LTD now owns 1,849,598 shares of the health services provider’s stock worth $345,764,000 after acquiring an additional 483,904 shares during the last quarter. FMR LLC boosted its position in CIGNA by 6.7% during the second quarter. FMR LLC now owns 6,909,638 shares of the health services provider’s stock worth $1,156,604,000 after acquiring an additional 432,978 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its position in CIGNA by 4,082.8% during the second quarter. Arrowstreet Capital Limited Partnership now owns 438,231 shares of the health services provider’s stock worth $73,355,000 after acquiring an additional 427,754 shares during the last quarter. Vanguard Group Inc. boosted its position in CIGNA by 2.5% during the second quarter. Vanguard Group Inc. now owns 17,130,735 shares of the health services provider’s stock worth $2,867,514,000 after acquiring an additional 424,469 shares during the last quarter. Finally, Numeric Investors LLC boosted its position in CIGNA by 76.0% during the second quarter. Numeric Investors LLC now owns 714,702 shares of the health services provider’s stock worth $119,634,000 after acquiring an additional 308,702 shares during the last quarter. Hedge funds and other institutional investors own 87.74% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “CIGNA Co. (CI) EVP John M. Murabito Sells 28,037 Shares” was first reported by Community Financial News and is the property of of Community Financial News. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The original version of this news story can be accessed at https://www.com-unik.info/2018/01/15/cigna-co-ci-evp-john-m-murabito-sells-28037-shares.html.

About CIGNA

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Insider Buying and Selling by Quarter for CIGNA (NYSE:CI)

Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit